✨ Free AI Report
Mind Medicine (MindMed) Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Mind Medicine (MindMed) Inc.
Research Preview

Mind Medicine (MindMed) Inc.: Business Overview, Financials & Competitive Analysis

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is a late-stage clinical biopharmaceutical company focused on developing novel product candidates to treat brain health disorders. The company is a clinical-stage psychedeli...

Analyst-debate audio for Mind Medicine (MindMed) Inc.

AskCyborg analysts argue the bull and bear cases for Mind Medicine (MindMed) Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Mind Medicine (MindMed) Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

Clinical-stage psychedelic biotech with advancing Phase 3 programs in high-need psychiatric disorders, backed by institutional...

Read the full analyst-debate transcript →
Industry Biopharmaceutical (Psychedelic Therapeutics)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 13, 2026
AI-Verified Research
30+ Page Report

Get the Latest Mind Medicine (MindMed) Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Mind Medicine (MindMed) Inc. Overview

Pro stress-test →

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is a late-stage clinical biopharmaceutical company focused on developing novel product candidates to treat brain health disorders. The company is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.

Strategic Profile

Pro stress-test →

MindMed concentrates on brain health disorders, including generalized anxiety disorder (GAD), major depressive disorder (MDD) and autism spectrum disorder (ASD). The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT and an ibogaine derivative, 18-MC.

Competitive Landscape

Pro stress-test →

MindMed competes in the emerging psychedelic therapeutics space against clinical-stage biotech companies developing novel psychiatric treatments. Key competitive vectors include speed to regulatory approval for Phase 3 programs, differentiated formulations, and mechanism diversity across psychedelic compounds.

Industry Context

Mind Medicine (MindMed) Inc. operates in Biopharmaceutical (Psychedelic Therapeutics).

Key facts

Founded: 2017 · Headquarters: Reno, US · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Mind Medicine (MindMed) Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Mind Medicine (MindMed) Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compass PathwaysPsilocybin-based depression treatment development→Atai Life SciencesPsychedelic and digital mental health platform→Usona InstitutePsilocybin research for major depressive disorder→

Compare Mind Medicine (MindMed) Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Mind Medicine (MindMed) Inc. operates in Biopharmaceutical (Psychedelic Therapeutics). See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical (Psychedelic Therapeutics) research →
NEW · MCP server

Ask your AI assistant about Mind Medicine (MindMed) Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Mind Medicine (MindMed) Inc. and its top competitor on Cyborg Score”
“What did Mind Medicine (MindMed) Inc. do this quarter?”
“Is Mind Medicine (MindMed) Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Mind Medicine (MindMed) Inc. do?+
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is a late-stage clinical biopharmaceutical company focused on developing novel product candidates to treat brain health disorders. The company is a clinical-stage psychedeli...
What is Mind Medicine (MindMed) Inc.'s Cyborg Score?+
Mind Medicine (MindMed) Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Mind Medicine (MindMed) Inc.'s main competitors?+
Named competitors include Compass Pathways, Atai Life Sciences, Usona Institute. The full competitive landscape is in the AskCyborg report.
How can I get the full Mind Medicine (MindMed) Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Mind Medicine (MindMed) Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Mind Medicine (MindMed) Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.